logo

For the Inventor, By the Inventor

Beijing, China

Le Sun

This inventor holds 16 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Display Technology. Top assignees: Boe Technology Group Co., Ltd., Ordos Yuansheng Optoelectronics Co., Ltd., A&g Pharmaceutical, Inc.. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Le Sun. Retrieved from https://idiyas.com/inventor/le-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 68.8

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Ellicott City, MD (US) (2007 - 2009)
  • Beijing, CN (2008 - 2023)

Company Filing History:

goldMedal8 out of 20,022 
 
Boe Technology Group Co., Ltd.
 patents
silverMedal8 out of 664 
 
Ordos Yuansheng Optoelectronics Co., Ltd.
 patents
bronzeMedal4 out of 18 
 
A&g Pharmaceutical, Inc.
 patents
4. 2 out of 1,371 
 
Yale University
 patents
5. 1 out of 1 
 
Abmax Biotechnology Co., Ltd.
 patent
6. 1 out of 1 
 
Welson Pharmaceuticals, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Backlight Device
Display Panel
Liquid Crystal Display
Electrostatic Test
Monoclonal Antibodies
Tumor Suppression
Color Filter Substrate
Detection Device
Cancer Therapeutics
Manufacturing Method
Data Line Detection
Humanized Antibodies
16 patents (USPTO):Explore Patents
1. 11835749 - Backlight and display device (2023-12-05),
2. 11497799 - Dickkopf2 (Dkk2) inhibition suppresses tumor formation (2022-11-15),
3. 11237437 - Display panel and manufacture method thereof, and display apparatus (2022-02-01),
4. 11231610 - Display panel and display apparatus (2022-01-25),
5. 11088172 - Array substrate and manufacturing method thereof, liquid crystal display panel and liquid crystal apparatus (2021-08-10),
6. 10977970 - Array substrate, display apparatus, detecting apparatus and detecting method for detecting defect connection of data line (2021-04-13),
7. 10941196 - Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereof (2021-03-09),
8. 10802063 - Detection device and detection method (2020-10-13),
9. 10690711 - Electrostatic test device for display module (2020-06-23),
10. 10611833 - Humanized anti-human epidermal growth factor receptor antibody and application thereof (2020-04-07),
11. 10398765 - Dickkopf2 (Dkk2) inhibition suppresses tumor formation (2019-09-03),
12. 10216332 - Color filter substrate and in-cell touch display device (2019-02-26),
13. 8088373 - Autocrine growth factor receptor antibodies and methods (2012-01-03),
14. 7560095 - Cancer specific monoclonal antibodies (2009-07-14),
15. 7411045 - Autocrine growth factor receptor antibodies and methods (2008-08-12),

Title: Le Sun: Innovator in Display Technology and Cancer Treatment

Introduction

Le Sun is a prominent inventor based in Beijing, China, known for his significant contributions to display technology and cancer treatment. With a total of 16 patents to his name, he has made remarkable advancements that aim to improve visual effects in display devices and enhance cancer therapies.

Latest Patents

One of Le Sun's latest patents is focused on a backlight and display device. This invention is related to the field of display technology and aims to improve the visual effect of images displayed by the device. The backlight includes a back plate, a light guide plate, and a light source. The design features an accommodation groove in the back plate and a holding groove in the light guide plate, which is configured to hold light-emitting elements. This innovative approach enhances the overall display quality.

Another significant patent involves the inhibition of Dickkopf2 (DKK2) to suppress tumor formation. This invention reveals that inhibiting DKK2 increases CD8 cytotoxic T lymphocyte activity and reduces tumor angiogenesis. The methods described in this patent relate to treating cancer by administering a DKK2 gene-depleting agent, providing anti-tumor immunity, and diagnosing cancer predispositions. This invention also includes a pharmaceutical composition for cancer treatment.

Career Highlights

Le Sun has worked with notable companies such as Ordos Yuansheng Optoelectronics Co., Ltd. and BOE Technology Group Co., Ltd. His experience in these organizations has contributed to his expertise in display technology and medical innovations.

Collaborations

Le Sun has collaborated with several professionals in his field, including Ginette Serrero and Tianlei Shi. These collaborations have likely enriched his research and development efforts.

Conclusion

Le Sun's innovative work in display technology and cancer treatment showcases his dedication to advancing these critical fields. His patents reflect a commitment to improving both visual technology and healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…